TCTR20221014001已完成2 期
Comparison of adjunctive middle meningeal artery embolization and surgical drainage alone for chronic subdural hematoma: A prospective pilot study
Faculty of medicine, Thammasat university0 个研究点目标入组 50 人开始时间: 2022年10月14日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
This study suggests that adjunctive MMAE is a promising addition to surgical drainage for the treatment of CSDH. MMAE shows acceptable safety and is associated with significant hematoma reduction and a potential decrease in recurrent cases compared to SDA. These findings warrant further exploration through a randomized trial to validate the efficacy of MMAE in CSDH management.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •All patients with age >= 18 years old who diagnosed with chronic subdural hematoma
排除标准
- •1.Had previous brain surgery within 3 months
- •2.GCS < 5 or NIHSS < 5
- •3.CSDH from brain tumor, vascular diseases
- •4.Pregnancy
- •5.chronic kidney disease or ongoing dialysis
- •6.infratentorium intracerebral hemorrhage
- •7.bed ridden or vegetative state
- •8.Patients with dangerous ECA anastomoses
研究者
相似试验
尚未招募
不适用
The role of middle meningeal artery embolisation as primary treatment for chronic subdural haematoma in adult patientsACTRN12621000202864The Canberra Hospital72
招募中
不适用
The role of middle meningeal artery embolisation as post-operative adjunct treatment for chronic subdural haematoma in adult patientsACTRN12621000263897The Canberra Hospital36
已完成
不适用
Middle Meningeal Artery Embolization for Treatment of Chronic Subdural HematomaChronic Subdural HematomaNCT03307395Weill Medical College of Cornell University6
招募中
不适用
Embolization of Middle Meningeal Artery for Subdural Hematoma in Canada (EMMA Can)Subdural HematomaNCT04923984University of Manitoba1,000
撤回
不适用
Middle Meningeal Artery Embolization for Chronic Subdural HematomaChronic Subdural HematomaNCT04065113Washington University School of Medicine600